Target Group Inc.
CBDY · OTCMCIK 1586554fmd_0QKVW21R78VPE9Y8SZ3YYPY3R9Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2013 to Jun 30, 2026, 52 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 7 | 4 |
| Cost of revenue | – | – | – | 0 | 0 | – | 0 | 2 | 3 | 2 |
| Gross profit | – | – | – | 0 | 0 | – | 0 | 2 | 4 | 2 |
| Research and development | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Total operating expenses | 2 | 1 | 1 | 5 | 2 | 1 | 1 | 2 | 3 | 2 |
| Operating income | – | – | – | (5) | (2) | – | (1) | (0) | 1 | (0) |
| Interest expense | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest and investment income | – | – | – | – | – | – | – | – | 0 | 0 |
| Other non-operating income (expense) | – | (1) | (1) | (6) | (6) | 2 | (3) | 0 | (1) | (1) |
| Income before taxes | (2) | (2) | (2) | (10) | (7) | 0 | (5) | (0) | 0 | (1) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (2) | (2) | (2) | (10) | (7) | 0 | (5) | (0) | 0 | (1) |
| Net income | (2) | (2) | (2) | (10) | (7) | 0 | (5) | (0) | 0 | (1) |
| Net income to common shareholders | – | – | – | – | – | – | – | – | 0 | (1) |